POC Study in Partially Responsive Generalized Anxiety Disorder

PHASE2TerminatedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

PF-06372865.

Blinded PF 06372865 and matching placebo will be provided as tablets for oral administration.

Trial Locations (47)

10168

Fieve Clinical Research, Inc, New York

10549

Bioscience Research LLC, Mount Kisco

11235

SPRI Clinical Trials LLC, Brooklyn

11432

Comprehensive Clinical Development, Inc., Jamaica

11516

Neurobehavioral Research, Inc., Cedarhurst

19063

Suburban Research Associates, Media

21208

Pharmasite Research Inc, Baltimore

30005

Institute for Advanced Medical Research, Alpharetta

30076

Northwest Behavioral Research Center, Roswell

30331

Atlanta Center for Medical Research, Atlanta

32025

Sarkis Clinical Trials, Lake City

32256

Clinical Neuroscience Solutions, Inc., Jacksonville

32607

Sarkis Clinical Trials, Gainesville

32720

Avail Clinical Research, LLC, DeLand

32763

Medical Research Group of Central Florida, Orange City

32801

Clinical Neuroscience Solutions, Inc., Orlando

33016

Berma Research Group, Hialeah

33613

Stedman Clinical Trials, Tampa

33912

Gulfcoast Clinical Center, Fort Meyers

38119

Clinical Neuroscience Solutions, Inc., Memphis

45215

Patient Priority Clinical Sites, LLC, Cincinnati

45227

CTI Clinical Research Center, Cincinnati

60640

Great Lakes Clinical Trials, Chicago

66206

Phoenix Medica Research, Inc, Prairie Village

68526

Premier Psychiatric Research Institute. LLC., Lincoln

73116

Cutting Edge Research Group, Oklahoma City

75115

InSite Clinical Research, LLC, DeSoto

75231

Futuresearch Trials of Dallas, Dallas

77381

Family Psychiatry of The Woodlands, The Woodlands

90703

Comprehensive Clinical Development, Inc., Cerritos

91316

Pharmacology Research Institute, Encino

91786

Pacific Clinical Research Medical Group, Upland

92056

Excell Research, Inc., Oceanside

92102

California Neuorpsychopharmacology Clinical Research Institute, LLC (CNRI-San Diego, LLC), San Diego

92103

Artemis Institute for Clinical Research, San Diego

92251

Sun Valley Research Center, Imperial

92868

NRC Research Institute, Orange

97210

Summit Research Network (Oregon) Inc., Portland

98007

Northwest Clinical Research Center, Bellevue

98104

Summit Research Network (Seattle) LLC, Seattle

06102

Hartford Hospital, Hartford

06106

Institute of Living, Hartford

02301

Beacon Clinical Research, LLC, Brockton

01844

ActivMed Practices & Research, Inc, Methuen

07160

BCCR Trials, Natick

08002

Center for Emotional Fitness, Cherry Hill

08755

Bio Behavioral Health, Toms River

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02310568 - POC Study in Partially Responsive Generalized Anxiety Disorder | Biotech Hunter | Biotech Hunter